Related references
Note: Only part of the references are listed.Extension of human cell lifespan by nicotinamide phosphoribosyltransferase
Eric van der Veer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Telomere biology and cardiovascular disease
Jose J. Fuster et al.
CIRCULATION RESEARCH (2006)
Survivin regulation of vascular injury
Michael S. Conte et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2006)
Activation of peroxisome proliferator-activated receptor γ suppresses telomerase activity in vascular smooth muscle cells
D Ogawa et al.
CIRCULATION RESEARCH (2006)
Sorting out the roles of PPARα in energy metabolism and vascular horneostasis
P Lefebvre et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Going nuclear in metabolic and cardiovascular disease
CK Glass
JOURNAL OF CLINICAL INVESTIGATION (2006)
Acute antiinflammatory properties of statins involve peroxisome proliferator-activated receptor-α via inhibition of the protein kinase C signaling pathway
R Paumelle et al.
CIRCULATION RESEARCH (2006)
PPARα inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a
F Gizard et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Telomeres and human disease: Ageing, cancer and beyond
MA Blasco
NATURE REVIEWS GENETICS (2005)
Pre-B-cell colony-enhancing factor regulates NAD+-dependent protein deacetylase activity and promotes vascular smooth muscle cell maturation
E van der Veer et al.
CIRCULATION RESEARCH (2005)
Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension
MS McMurtry et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Survivin enhances telomerase activity via up-regulation of specificity protein 1-and c-Myc-mediated human telomerase reverse transcriptase gene transcription
T Endoh et al.
EXPERIMENTAL CELL RESEARCH (2005)
Regulation of human ApoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor α modulation
H Duez et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Aberrant regulation of survivin by the RB/E2F family of proteins
YY Jiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Aging exacerbates negative remodeling and impairs endothelial regeneration after balloon injury
D Torella et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Living with or without cyclins and cyclin-dependent kinases
CJ Sherr et al.
GENES & DEVELOPMENT (2004)
The role of telomerase activation in the regulation of vascular smooth muscle cell proliferation
T Minamino et al.
DRUG NEWS & PERSPECTIVES (2003)
Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies
VJ Dzau et al.
NATURE MEDICINE (2002)
Opposing regulatory roles of E2F in human telomerase reverse transcriptase (hTERT) gene expression in human tumor and normal somatic cells
JJ Won et al.
FASEB JOURNAL (2002)
Direct evidence for the importance of p130 in injury response and arterial remodeling following carotid artery ligation
JR Sindermann et al.
CARDIOVASCULAR RESEARCH (2002)
E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex
JB Rayman et al.
GENES & DEVELOPMENT (2002)
New ways not to make ends meet: telomerase, DNA damage proteins and heterochromatin
SWL Chan et al.
ONCOGENE (2002)
E2F-1 represses transcription of the human telomerase reverse transcriptase gene
DL Crowe et al.
NUCLEIC ACIDS RESEARCH (2001)
Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT)
JC Poole et al.
GENE (2001)
Identification of a subtype selective human PPARα agonist through parallel-array synthesis
PJ Brown et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Requirements for cell cycle arrest by p16INK4a
JL Bruce et al.
MOLECULAR CELL (2000)
Rb function in cell-cycle regulation and apoptosis
JW Harbour et al.
NATURE CELL BIOLOGY (2000)
The PPARs: From orphan receptors to drug discovery
TM Willson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
